Axsome Therapeutics (NASDAQ:AXSM – Free Report) had its price objective increased by UBS Group from $251.00 to $259.00 in a research note released on Friday morning, MarketBeat Ratings reports. They currently have a buy rating on the stock. AXSM has been the subject of several other research reports. Royal Bank Of Canada boosted their target […]

Universal Logistics (NASDAQ:ULH – Free Report) had its price objective upped by Stifel Nicolaus from $17.00 to $20.00 in a research report sent to investors on Tuesday,Benzinga reports. The brokerage currently has a hold rating on the transportation company’s stock. A number of other analysts have also weighed in on ULH. Zacks Research upgraded shares […]

Taysha Gene Therapies (NASDAQ:TSHA – Free Report) had its target price upped by Canaccord Genuity Group from $14.00 to $17.00 in a report published on Monday morning,Benzinga reports. They currently have a buy rating on the stock. Several other brokerages have also recently issued reports on TSHA. Raymond James Financial reaffirmed a “strong-buy” rating and […]

Academy Sports and Outdoors (NASDAQ:ASO – Get Free Report) had its target price lifted by Guggenheim from $60.00 to $65.00 in a research report issued on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Guggenheim’s target price points to a potential upside of 13.68% from the company’s current price. Several other […]

United Therapeutics (NASDAQ:UTHR – Free Report) had its price objective lifted by HC Wainwright from $600.00 to $660.00 in a research report released on Tuesday morning,Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. HC Wainwright also issued estimates for United Therapeutics’ Q1 2026 earnings at $6.77 EPS, Q2 2026 earnings […]

United Therapeutics (NASDAQ:UTHR – Free Report) had its target price raised by Wells Fargo & Company from $486.00 to $575.00 in a research note published on Tuesday,Benzinga reports. The brokerage currently has an equal weight rating on the biotechnology company’s stock. Several other research analysts have also weighed in on UTHR. Oppenheimer increased their price […]

Bicara Therapeutics (NASDAQ:BCAX – Free Report) had its target price hoisted by HC Wainwright from $40.00 to $42.00 in a report issued on Tuesday morning,Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Bicara Therapeutics’ Q1 2026 earnings at ($0.64) EPS, Q2 2026 earnings at ($0.62) […]

United Therapeutics (NASDAQ:UTHR – Get Free Report) had its price target increased by stock analysts at Wells Fargo & Company from $486.00 to $575.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has an “equal weight” rating on the biotechnology company’s stock. Wells Fargo & Company‘s target price would indicate […]

Apogee Therapeutics (NASDAQ:APGE – Get Free Report) had its price target lifted by investment analysts at Mizuho from $105.00 to $110.00 in a report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Mizuho’s price target would suggest a potential upside of 40.26% from the company’s previous close. Other research […]

Sarepta Therapeutics (NASDAQ:SRPT – Free Report) had its price target hoisted by Citigroup from $9.00 to $13.00 in a research report sent to investors on Thursday morning,Benzinga reports. The firm currently has a sell rating on the biotechnology company’s stock. A number of other research firms have also issued reports on SRPT. Needham & Company […]